Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214823
Company: MSN
Company: MSN
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 3MG BASE | TABLET;ORAL | Prescription | BX | No | No |
| DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | EQ 6MG BASE | TABLET;ORAL | Prescription | BX | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 04/03/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
DOXEPIN HYDROCHLORIDE
There are no Therapeutic Equivalents.